Skip to content

Stock-Based Comp at other companies

Abbott logo
AbbottABT
$317M+9.7%
Baxter International logo
Baxter InternationalBAX
$10M0.0%
TFX
TeleflexTFX
$6.74M+1.7%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$83M+10.7%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$6.6M+408%
Danaher logo
DanaherDHR
$58M-4.9%

Other financials

Income statement

See full
Revenue$4.7B+5.2%
Gross profit$2.2B+15.7%
Operating income$93.0M-75.7%
Net income-$311.0M-201%
EPS (diluted)-$1.11-204%

Balance sheet

See full
Cash & equivalents$1.0B+49.0%
Total debt$14.7B-16.8%
Total equity$24.1B-4.4%
Total assets$50.8B-6.7%

Cash flow

See full
Operating cash flow$671.0M
CapEx$125.0M+9.6%
Free cash flow$546.0M

Valuation

See full
Market cap$42.96B-12.6%
Enterprise value$56.65B-14.0%
P/E37.8×+6.7×
P/S-0.4×

Profitability

See full
Gross margin46.8%+2.5pp
Operating margin10.4%+0.1pp
Net margin5.3%-2.1pp
FCF margin16.4%

Returns & leverage

See full
Return on equity4.6%-1.3pp
Debt / equity0.6×-0.1×
Current ratio0.9×-0.2×

Where this comes from

Reported directly by Becton, Dickinson and Company in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Becton, Dickinson and Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Becton, Dickinson and Company's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Becton, Dickinson and Company's stock-based comp?
Becton, Dickinson and Company (BDX) reported stock-based comp of $58M in Q1 2026.
How has Becton, Dickinson and Company's stock-based comp changed year-over-year?
Becton, Dickinson and Company's stock-based comp increased by 41.5% year-over-year, from $41M to $58M.
What is the long-term trend for Becton, Dickinson and Company's stock-based comp?
Over 4 years (2021 to 2025), Becton, Dickinson and Company's stock-based comp has grown at a 3.0% compound annual growth rate (CAGR), from $229M to $258M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.